carbachol has been researched along with Chagas Disease in 2 studies
Carbachol: A slowly hydrolyzed CHOLINERGIC AGONIST that acts at both MUSCARINIC RECEPTORS and NICOTINIC RECEPTORS.
Chagas Disease: Infection with the protozoan parasite TRYPANOSOMA CRUZI, a form of TRYPANOSOMIASIS endemic in Central and South America. It is named after the Brazilian physician Carlos Chagas, who discovered the parasite. Infection by the parasite (positive serologic result only) is distinguished from the clinical manifestations that develop years later, such as destruction of PARASYMPATHETIC GANGLIA; CHAGAS CARDIOMYOPATHY; and dysfunction of the ESOPHAGUS or COLON.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Carlucci, W | 1 |
| Ceneviva, R | 1 |
| Ferreira, SH | 1 |
| Silva, OC | 1 |
| Vila Echagüe, A | 1 |
| Sterin-Borda, L | 1 |
2 other studies available for carbachol and Chagas Disease
| Article | Year |
|---|---|
Histological, biochemical and pharmacological characterization of the gastric muscular layer in Chagas disease.
Topics: Acetylcholine; Acetylcholinesterase; Adult; Carbachol; Case-Control Studies; Cell Count; Chagas Dise | 2011 |
Negative inotropic effect of chagasic IgG mediated by nitric oxide.
Topics: Animals; Carbachol; Chagas Disease; Cyclic GMP; Depression, Chemical; Enzyme Inhibitors; Heart Atria | 1996 |